General News

General News | May. 20, 2011

European Review Board Issues Positive Opinion for Benlysta®

The European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion, recommending marketing authorisation for BENLYSTA®.

General News | May. 13, 2011

Lupus Foundation of America Presents at National Institutes of Health Lessons in Lupus Event

Dario Dieguez, PhD, from the Lupus Foundation of America joined leading NIH lupus experts to explore current issues in lupus, including risk factors and treatment therapies.

General News | Apr. 13, 2011

Lupus Foundation of America and RN.com Launch New Lupus Education Program

Program provides lupus education to nurses, pharmacists, and pharmacy technicians.

General News | Mar. 09, 2011

LFA Applauds FDA Decision to Approve Benlysta for the Treatment of Lupus

The U.S. Food and Drug Administration (FDA) approved the drug, BENLYSTA®, for the treatment of lupus, an autoimmune disease.

General News | Feb. 08, 2011

Human Genome Sciences and GlaxoSmithKline Announce Publication Phase 3 Study Results for BENLYSTA®

Human Genome Sciences and GlaxoSmithKline announced publication of the BLISS-52 study of BENLYSTA®.